未知生产厂商
Ty800 is a vaccine designed to offer rapid, oral, single-dose protection against Salmonella typhi, the cause of typhoid fever. The Ty800 vaccine was developed using genetic techniques to delete specific genes known to be essential to the virulence of S. typhi. It is being developed by AVANT Immunotherapeutics, Inc.
Ty800 is a vaccine designed to offer rapid, oral, single-dose protection against Salmonella typhi, the cause of typhoid fever. The Ty800 vaccine was developed using genetic techniques to delete specific genes known to be essential to the virulence of S. typhi. It is being developed by AVANT Immunotherapeutics, Inc.
Ty800 is a vaccine developed via the deletion of the phoP/phoQ virulence regulatory genes of Salmonella typhi Ty2. This enables the immune system to detect the applicable antibodies present on the natural virus without risking the patient.
For the production of immunity to Salmonella typhi, the cause of typhoid fever.
